This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nakajima, H. Articles by Kitamura, S. Search for Related Content PubMed PubMed Citation Articles by Nakajima, H. Articles by Kitamura, S. Pubmed/NCBI databases Medline Plus Health Information Atrial Fibrillation Heart Valve Diseases

(Circulation. 2002;106:I-46.)
© 2002 American Heart Association, Inc.

Surgery for Valvular Heart Disease

The Effect of Cryo-Maze Procedure on Early and Intermediate Term Outcome in Mitral Valve Disease: Case Matched Study

Hiroyuki Nakajima, MD; Junjiro Kobayashi, MD; Ko Bando, MD; Kazuo Niwaya, MD; Osamu Tagusari, MD; Yoshikado Sasako, MD; Takeshi Nakatani, MD; Soichiro Kitamura, MD

From the Department of Cardiovascular Surgery, National Cardiovascular Center, Osaka, Japan.

Correspondence to Junjiro Kobayashi, MD, Department of Cardiovascular Surgery, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan. E-mail jkobayas{at}hsp.ncvc.go.jp

Background The maze procedure is an effective way to treat atrial fibrillation (AF) associated with mitral valve disease. In a last several years, cryoablation was substituted for atrial incision in many reports to simplify the maze procedure. However, there has been no comparative study to delineate the feasibility of the use of cryoablation.

Methods and Results We compared the early and intermediate-term results of the maze procedure including pulmonary venous isolation from the left atrium using cryoablation (CM) with our conventional (Kosakai) maze procedure (KM) including encircling incision around the orifices of pulmonary veins. One hundred and 10 pairs of patients were matched in the age, left atrial dimension >70 mm, duration of AF >0 years, previous cardiac surgery, mechanical valve implantation and concomitant aortic valve procedures. CM required significantly shorter cardiopulmonary bypass time (186±56 minute versus 214±47 minute, P=0.001) and aortic cross-clamp time (134±43 minute versus 144±37 minute, P=0.03) than KM with less chest tube drainage (590±353 mL versus 745±618 mL, P=0.02) for 12 hours after operation. The sinus rhythm restoration rate in CM group (85.4%) was comparable with KM group (86.4%) at discharge. In the late results, the actuarial freedom from recurrence of sustained AF at 3 years in CM group (97.7%) was not significantly (P=0.11) different from that in KM group (90.4%). The actuarial freedom from stroke at 3 years in CM group was 99.0%.

Conclusion The modification of the maze procedure including cryoablation for pulmonary venous isolation provided less aortic cross-clamp time and less amount of chest tube drainage with the comparable recovery and maintenance of sinus rhythm with KM. CM is a reliable and less invasive surgical option for the AF associated with mitral valve disease.

Key Words: mitral valve disease • maze procedure • atrial fibrillation • cryoablation